
About Causaly
Causaly is a Healthcare company based in London (United Kingdom) founded in 2017. AI-based data-mining tools for scientific evidence discovery are provided. Causaly has raised $90.72 million across 5 funding rounds from investors including EBRD, Iconiq Capital and Index Ventures. The company has 62 employees. Its website causaly.com draws about 39 thousand monthly visits. Causaly offers products and services including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its legal entity is CAUSALY LTD.
Company details
Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.
- Headquarters London, United Kingdom
- Employees 62
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website causaly.com
- Social LinkedIn X
- Legal Name Causaly Ltd
- Date of Incorporation 17 May, 2018
- Jurisdiction LONDON, ENGLAND
- Total Equity Funding$90.72M (USD)
in 5 rounds
- Latest Funding Round$60M (USD), Series B
Jul 2023
- InvestorsEBRD
& 14 more
- Employee Count62
Products & Services of Causaly
Causaly offers a comprehensive portfolio of products and services, including AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.
Unified system for life sciences R&D using AI and knowledge graphs.
Tool for querying and analyzing biomedical data with citations.
High-precision graph for causal relationships in life sciences.
Platform to consolidate internal and external data for R&D.
System for accurate retrieval of life sciences information.
Funding Insights of Causaly
Causaly has successfully raised a total of $90.72M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $60 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $90.72M
- Total Rounds 5
- Last Round Series B β $60M
- First Round $1.2M
(Jul 2018)
- Investors Count 15
All 5 funding rounds of Causaly with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2023 | $60M | Series B | β | Iconiq Capital | |
| Oct 2022 | $7.72M | Series A | β | β | β |
| May 2021 | $17M | Series A | β | Index Ventures | |
| Nov 2019 | $4.8M | Series A | β | Pentech, EBRD | |
| Jul 2018 | $1.2M | Seed | β | Marathon Venture Capital |
15 investors in total: 9 institutional and 6 angel.
Investors in Causaly
Causaly has secured backing from 15 investors, including venture fund and angel investors. Prominent investors backing the company include EBRD, Iconiq Capital and Index Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of investment management and real asset services | iconiqcapital.com | San Francisco, United States | ||
Venture capital investments in technology startups and entrepreneurs. | indexventures.com | |||
Venture capital funding is provided to early-stage startups. | marathon.vc | Athens, Greece | ||
Venture capital funding is provided for early-stage software companies. | pentechvc.com | Edinburgh, United Kingdom | ||
Visionaries Club is engaged in venture capital investments for B2B tech startups. | visionaries.vc | Berlin, Germany | ||
Corporate advisory services are provided across multiple sectors. | 1991 | ebrd.com | London, United Kingdom | |
UK tech and offline companies are funded by Pentech. | pentech.vc | Edinburgh, United Kingdom | ||
Early-stage tech investments are made in Europe and Asia. | ebrdvcip.com | London, United Kingdom | ||
A pre-seed fund is managed to support early-stage founders. | emergecapital.vc | London, United Kingdom | ||
OP Olivier Pomel | Co-founder & CEO of Datadog, active angel investor in tech startups | unknown_107d9cdaa0af402c8 |
Investor details for Causaly
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Causaly
46 people are tracked at Causaly (18 in leadership, 28 in team); the tracked headcount is 62.
| Name | Role | Group |
|---|---|---|
Isra Salim | VP Product | Leadership |
Guilherme de Oliveira Pinheiro | Senior Vice President Global Sales | Leadership |
Marcel Karnstedt Hulpuş | Director Of Data And Semantic Technologies | Leadership |
Yiannis Kiachopoulos | Co-founder & CEO | Leadership |
Artur Saudabayev | Co-founder & CTO | Leadership |
Andy Grygiel | Chief Marketing Officer | Leadership |
Matthew Polletta | Director Of Strategic Accounts | Leadership |
Stefanos Leptidis | Head Of Biomedical Information Sciences | Leadership |
Marco Costa | COO | Leadership |
Michael Zoidis | Head Of Product Design | Leadership |
Alan Davies | Head Of IT Security | Leadership |
Maria Loufardaki | People Director | Leadership |
Chris Harrison | Talent Partner | Leadership |
Mireia Puignou | People Operations Partner | Leadership |
Damir Dosymbekov | Head Of Product | Leadership |
Alexandra Lemacon | Senior Director, Life Sciences Strategy EMEA | Leadership |
Dimitrios Michalakos | Director Of Application Engineering | Leadership |
Rui Miguel Forte | Director Of Engineering (nlp/ml) | Leadership |
Mark Goodwin | Senior Staff Security Engineer | Team |
Nikos Kalogridis | Software Architect | Team |
26 more people are available in the full profile.
Complete people profiles for Causaly
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Causaly
3 dated milestones of Causaly across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Causaly is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series B, of $60.0M.
Web traffic of Causaly
The website of Causaly (causaly.com) receives about 38.8K visits a month.
- Monthly visits38.8K
▲ 80% vs previous month
Websites whose visitors overlap most with Causaly. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| papersapp.com | 100% | 81.4K | #493,194 | View details | |
| scite.ai | 56% | 885.4K | #61,043 | View details | |
| scispace.com | 54% | 4.8M | #12,888 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Causaly (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Causaly
Complete news archive for Causaly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Causaly
Causaly was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Causaly is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Causaly is a funded company, having raised a total of $90.72M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Jul 2018.
Causaly has 62 employees.
Causaly was founded in 2017 and is headquartered in London, United Kingdom. The company operates in the biomedical AI sector, where software is developed to extract evidence from academic publications, clinical trials, regulatory documents, patents, and other sources. Hidden causal relationships in biomedical data are identified and curated through this technology, supporting researchers in cause-and-effect analysis.
Causaly offers AI Platform, Generative AI Copilot, Knowledge Graph, Enterprise Data Fabric, and Scientific RAG.
Causaly has 15 investors. Key investors include EBRD, Iconiq Capital, Index Ventures, Marathon Venture Capital, and Pentech.
Causaly operates through Causaly Ltd.
